Ingersoll was one of many industrials that decided to tighten its belt in 2008, cutting its overhead costs and ultimately ensuring that more of every dollar it brings in makes it to the bottom line of its income statement. That's helped to generate net profit margins approaching 10% in the last year. IR's brands may not be particularly complementary, but they are mainly league-leaders in their respective niches, a fact that provides for premium pricing and a stickier customer base of after market parts.
To be sure, Ingersoll still isn't in a "normal" market for its products. Despite a pickup in construction, building is still depressed from prerecession levels. When those numbers start to pick up again, particularly on the commercial side, Ingersoll-Rand should benefit disproportionately.
In the meantime, a reasonable balance sheet and a growing emerging markets business should help investors wait things out. Just keep an eye on Friday's earnings call.ResMed Medical device maker RedMed (RMD) rounds out our list of Rocket Stocks this week. RMD's primary business is in manufacturing airflow generators and masks for sleep apnea patients, a business that could provide a springboard for ResMed to move into other breathing disorders with underserved device markets. The firm announces its next round of earnings on Oct. 25. ResMed has built a business on being innovative. When the firm decided to move into the sleep apnea business, it used superior technology to take market share from the medical device makers who held the top spots. As RMD continues to innovate, it should open up new markets. New pushes toward home testing of sleep apnea should help lift the fortunes of all the medical device makers in the business, but a push toward treating other related breathing disorders holds the most promise in the longer-term. Financially, ResMed is in good shape, with around $560 million in net cash on its balance sheet once debt is accounted for. Short sellers have historically mobilized against shares of ResMed, shoving the firm's short interest ratio in the double-digits and making this stock a good candidate for a short squeeze.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV